Effect of Interaction Between Gentamicin and Pyridoxal-5-Phosphate on Functional and Metabolic Parameters in Kidneys of Female Sprague-Dawley Rats

References

• Kacew S, Bergeron MG. Pathogenic factors in aminoglycoside-induced nephrotoxicity. Toxicol. Lett. 1990; 51: 241–259
   PubMed Web of Science ®Google Scholar
• Tulkens PM. Nephrotoxicity of aminoglycoside antibiotics. Toxicol. Lett. 1989; 46: 107–123
   PubMed Web of Science ®Google Scholar
• Kosek J C, Mazze R I, Cousins MJ. Nephrotoxicity of gentamicin. Lab. Invest 1974; 30: 48–57
   PubMed Web of Science ®Google Scholar
• Toubeau G, Maldague P, Laurent G, Vaamonde C A, Tulkens P M, Heuson-Stiennon JA. Morphological alterations in distal and collecting tubules of the rat renal cortex after aminoglycoside administration at low doses. Virchows Arch. (Cell Pathol) 1986; 51: 475–485
   Google Scholar
• Feldman S, Wang M Y, Kaloyanides GJ. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: An early manifestation of nephrotoxicity. J. Pharmacol. Exp. Ther. 1982; 220: 514–520
   PubMed Web of Science ®Google Scholar
• Kacew S. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: Role of tissue and species in manifestation of toxicity. J. Pharmacol. Exp. Ther. 1985; 232: 239–243
   PubMed Web of Science ®Google Scholar
• Kacew S. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: An in vivo comparative study with gentamicin and chlorphentermine. Toxciol. Appl. Pharmacol. 1987; 91: 469–476
   PubMed Web of Science ®Google Scholar
• Hostetler K Y, Jellison EJ. Inhibition of kidney lysosomal phospholipase A by aminoglycosides is a novel variant of substrate depletion inhibition. J. Pharmacol. Exp. Ther. 1990; 254: 188–191
   PubMed Web of Science ®Google Scholar
• Kaloyanides GJ. Aminoglycoside-induced functional and biochemical defects in the renal cortex. Fundam. Appl. Toxicol 1984; 4: 930–943
   PubMedGoogle Scholar
• Smetana S, Khalef S, Nitsan Z, Hurwitz N, Miskin A, Bar-Khayim Y, Birk Y. Enhanced urinary trypsin inhibitory activity in gentamicin-induced nephrotoxicity in rats. Clin. Chim. Acta 1988; 176: 333–342
   PubMed Web of Science ®Google Scholar
• Smetana S, Khalef S, Hurwitz N, Bar-Khayim Y, Birk Y. Influence of exogenous protease inhibitor (Bowman-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats. Contribution Nephrol. 1991; 83, in press
   Google Scholar
• Kacew S. Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5-phosphate in the rat. J. Pharmacol. Exp. Ther. 1989; 248: 360–366
   PubMed Web of Science ®Google Scholar
• Bennett W M, Parker R A, Elliott W C, Gilbert D N, Houghton DC. Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J. Infect. Dis. 1982; 145: 370–373
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Stanley G HS. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 1957; 226: 497–509
   PubMed Web of Science ®Google Scholar
• Rouser G, Siakotos A N, Fleischer S. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1966; 1: 85–86
   PubMed Web of Science ®Google Scholar
• Chen PS, Jr, Toribara T Y, Warner H. Microdetermination of phosphorus. Anal. Chem. 1956; 28: 1756–1758
   Web of Science ®Google Scholar
• Chasson A L, Grady H T, Stanley NA. Determination of creatinine by means of automatic chemical analysis. Am. J. Clin. Pathol. 1961; 35: 83–88
   Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Hummel BC. A modified spectrophotometric determination of chymotrypsin, trypsin and thrombin. Can. J. Biochem. Physiol. 1959; 37: 1393–1399
   PubMedGoogle Scholar
• Brenner B, Rector F. The Kidney3rd ed. Saunders, Philadelphia 1986
   Google Scholar
• Reasor M J, Ogle C L, Walker E R, Kacew S. Amiodarone-induced phospholipidosis in rat alveolar macrophages. Am. Rev. Resp. Dis. 1988; 137: 510–518
   PubMed Web of Science ®Google Scholar
• Mazue G, Vic P, Gouy D, Remandet B, Lacheretz F, Berthe J, Barchewitz G, Gagnol JP. Recovery from amiodarone-induced lipidosis in laboratory animals: a toxicological study. Fundam. Appl. Toxicol. 1984; 4: 992–999
   PubMedGoogle Scholar
• Ramsammy L S, Josepovitz C, Lane B P, Kaloyanides GJ. Polyaspartic acid protects against gentamicin nephrotoxcity in the rat. J. Pharmacol. Exp. Ther. 1989; 250: 149–153
   PubMedGoogle Scholar
• Koren G, Klein J, MacLeod SM. The dissociation between aminoglycoside serum concentrations and nephrotoxicity. Life Sci. 1988; 43: 1817–1823
   PubMed Web of Science ®Google Scholar
• Bergeron M G, Bergeron Y, Beauchamp D. Influence of hydrocortisone succinate on intrarenal accumulation of gentamicin in endotoxemic rats. Antimicrob. Agents Chemother. 1987; 31: 1816–1821
   PubMedGoogle Scholar
• Beauchamp D, Poirier A, Bergeron MG. Increased nephrotoxicity of gentamicin in pyelonephritic rats. Kidney Int. 1985; 28: 106–113
   PubMed Web of Science ®Google Scholar
• Moore R D, Smith C R, Lipsky J J, Mellits E D, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann. Intern. Med. 1984; 100: 352–357
   PubMed Web of Science ®Google Scholar
• Keniston R C, Cabellon S, Jr, Yarbrough KS. Pyridoxal-5-phosphate as an antidote for cyanide, spermine, gentamicin and dopamine toxicity: An in vivo rat study. Toxicol. Appl. Pharmacol. 1987; 88: 433–441
   PubMedGoogle Scholar
• Kojima R, Ito M, Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (8): Protective effect of pyridoxal-5-phosphate against tobramycin nephrotoxicity. Jpn. J. Pharmacol. 1990; 52: 11–21
   PubMedGoogle Scholar
• Weir M R, Keniston R C, Enriquez J I, McNamee GA. Depression of vitamin B6 levels due to gentamicin. Vet. Hum. Toxicol. 1990; 32: 235–238
   PubMedGoogle Scholar
• Hayashi T, Watanabe Y, Kumano K, Kitayama R, Yasuda T, Saikawa I, Katahira J, Kumada T, Shimizu K. Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals. Antimicrob. Agents Chemother. 1988; 32: 912–918
   PubMed Web of Science ®Google Scholar
• Ohnishi A, Bryant T D, Branch K R, Sabra R, Branch RA. Role of sodium in the protective effect of ticarcillin on gentamicin nephrotoxicity in rats. Antimicrob. Agents Chemother. 1989; 33: 928–932
   PubMedGoogle Scholar
• Kojima R, Ito M, Suzuki Y. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3): Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism. Jpn. J. Pharmacol. 1986; 42: 397–404
   PubMedGoogle Scholar
• Birk Y. Bowman-Birk inhibitor. Int. J. Peptide Protein Res. 1985; 25: 113–131
   PubMedGoogle Scholar